[CH3:1][S:2]/[C:3](=[N:16]\[C:17]1[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1)/[N:4]1[CH2:9][CH2:8][C:7]2[N:10]=[C:11]([C:13]([OH:15])=O)[S:12][C:6]=2[CH2:5]1.[C:23]([O:27][C:28](=[O:39])[NH:29][C:30]1[CH:35]=[CH:34][C:33](OC)=[CH:32][C:31]=1[NH2:38])([CH3:26])([CH3:25])[CH3:24].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.CN([CH:64]=[O:65])C>C(N(CC)CC)C>[C:23]([O:27][C:28]([NH:29][C:30]1[CH:35]=[C:34]([O:65][CH3:64])[CH:33]=[CH:32][C:31]=1[NH:38][C:13]([C:11]1[S:12][C:6]2[CH2:5][N:4]([C:3]([S:2][CH3:1])=[N:16][C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[CH2:9][CH2:8][C:7]=2[N:10]=1)=[O:15])=[O:39])([CH3:24])([CH3:25])[CH3:26]A suspension of 5-[(Z)-(methylthio)(phenylimino)methyl]-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxylic acid obtained from step III of example 116 (1 eq), (2-amino-4-methoxy-phenyl)-carbamic acid tert-butyl ester (1.2 eq), EDCI (1.2 eq), HOBt (1.2 eq) and triethylamine in DMF were stirred at room temperature for 15 h. Solvent was evaporated and the residue was purified by either column chromatography or preparative HPLC to afford methyl 2-({2-[(tert-butoxycarbonyl)amino]-4-methoxyphenyl}carbamoyl)-N-phenyl-6,7-dihydro[1,3]thiazolo[5,4-c]pyridine-5(4H)-carbimidothioate.
読み込み中…